The Chemours Company (NYSE:CC) Stock Holdings Increased by Sei Investments Co.

Sei Investments Co. lifted its holdings in shares of The Chemours Company (NYSE:CC - Free Report) by 779.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 174,555 shares of the specialty chemicals company's stock after purchasing an additional 154,709 shares during the period. Sei Investments Co. owned about 0.12% of Chemours worth $2,950,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Vision One Management Partners LP acquired a new stake in Chemours in the 3rd quarter worth about $28,252,000. Peregrine Capital Management LLC acquired a new stake in shares of Chemours in the fourth quarter worth approximately $5,731,000. Channing Capital Management LLC purchased a new stake in Chemours in the fourth quarter valued at approximately $4,701,000. Holocene Advisors LP increased its position in Chemours by 1,058.1% during the third quarter. Holocene Advisors LP now owns 194,465 shares of the specialty chemicals company's stock worth $3,952,000 after purchasing an additional 177,673 shares during the last quarter. Finally, Advisors Asset Management Inc. increased its position in Chemours by 146.6% during the fourth quarter. Advisors Asset Management Inc. now owns 235,238 shares of the specialty chemicals company's stock worth $3,976,000 after purchasing an additional 139,836 shares during the last quarter. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

CC has been the topic of several research analyst reports. Mizuho raised Chemours from a "neutral" rating to an "outperform" rating and set a $19.00 price objective on the stock in a research note on Thursday, March 27th. BMO Capital Markets decreased their price objective on shares of Chemours from $34.00 to $27.00 and set an "outperform" rating for the company in a research note on Wednesday, February 19th. Morgan Stanley cut their target price on shares of Chemours from $25.00 to $22.00 and set an "equal weight" rating on the stock in a research note on Monday, January 13th. Royal Bank of Canada reiterated an "outperform" rating and issued a $25.00 price target on shares of Chemours in a report on Thursday, December 12th. Finally, Barclays decreased their target price on Chemours from $19.00 to $16.00 and set an "equal weight" rating for the company in a research report on Tuesday, April 1st. Four equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $22.56.

Remove Ads

Chemours Stock Down 9.0 %

Shares of Chemours stock traded down $0.95 during trading hours on Tuesday, hitting $9.59. 4,376,204 shares of the company's stock traded hands, compared to its average volume of 1,791,920. The company has a quick ratio of 0.92, a current ratio of 1.68 and a debt-to-equity ratio of 6.70. The Chemours Company has a twelve month low of $9.47 and a twelve month high of $29.21. The stock has a 50 day simple moving average of $15.12 and a 200-day simple moving average of $17.82. The company has a market cap of $1.43 billion, a PE ratio of 16.82 and a beta of 1.84.

Chemours (NYSE:CC - Get Free Report) last posted its quarterly earnings data on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.01. The company had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.37 billion. Chemours had a return on equity of 26.54% and a net margin of 1.51%. Equities research analysts anticipate that The Chemours Company will post 2.03 earnings per share for the current fiscal year.

Chemours Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were issued a $0.25 dividend. The ex-dividend date of this dividend was Friday, February 28th. This represents a $1.00 annualized dividend and a yield of 10.43%. Chemours's dividend payout ratio is presently 175.44%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.